- Home
- BVS vs SITC Comparison
BVS vs SITC Comparison
Compare BVS & SITC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BVS
- SITC
- Stock Information
- Founded
- BVS 2011
- SITC 1965
- Country
- BVS United States
- SITC United States
- Employees
- BVS N/A
- SITC N/A
- Industry
- BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SITC Real Estate Investment Trusts
- Sector
- BVS Health Care
- SITC Real Estate
- Exchange
- BVS Nasdaq
- SITC Nasdaq
- Market Cap
- BVS 656.9M
- SITC 786.5M
- IPO Year
- BVS 2021
- SITC 1993
- Fundamental
- Price
- BVS $9.11
- SITC $12.86
- Analyst Decision
- BVS Strong Buy
- SITC Hold
- Analyst Count
- BVS 4
- SITC 8
- Target Price
- BVS $15.00
- SITC $35.25
- AVG Volume (30 Days)
- BVS 391.7K
- SITC 1.1M
- Earning Date
- BVS 03-11-2025
- SITC 04-29-2025
- Dividend Yield
- BVS N/A
- SITC 4.10%
- EPS Growth
- BVS N/A
- SITC 101.37
- EPS
- BVS N/A
- SITC 9.77
- Revenue
- BVS $573,280,000.00
- SITC $278,932,000.00
- Revenue This Year
- BVS N/A
- SITC N/A
- Revenue Next Year
- BVS $6.09
- SITC N/A
- P/E Ratio
- BVS N/A
- SITC $1.30
- Revenue Growth
- BVS 11.89
- SITC N/A
- 52 Week Low
- BVS $3.90
- SITC $12.47
- 52 Week High
- BVS $14.38
- SITC $64.44
- Technical
- Relative Strength Index (RSI)
- BVS 39.95
- SITC 39.49
- Support Level
- BVS $8.78
- SITC $12.60
- Resistance Level
- BVS $9.98
- SITC $13.27
- Average True Range (ATR)
- BVS 0.46
- SITC 0.28
- MACD
- BVS -0.06
- SITC 0.07
- Stochastic Oscillator
- BVS 12.14
- SITC 48.12
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.
About SITC SITE Centers Corp.
SITE Centers Corp is a United States-based self-administered and self-managed REIT that operates as a fully integrated real estate company. The company is engaged in the business of owning, leasing, acquiring, redeveloping, developing and managing shopping centers.